Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

MIRECC/CoE

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

Publications

Publications Since 2014

(Last Update: September 2016)

*Publications in gray denote duplicate listings due to collaboration between multiple MIRECC investigators

William Byne 16 of 76 (Total)

1: Byne W. Leaders in LGBT Health. LGBT Health. 2016 Jun;3(3):180. doi:10.1089/lgbt.2016.0053. Epub 2016 May 12. PubMed PMID: 27171916.

2: Byne W. Regulations Restrict Practice of Conversion Therapy. LGBT Health. 2016Apr;3(2):97-9. doi: 10.1089/lgbt.2016.0015. Epub 2016 Mar 18. PubMed PMID:26990275.

3: Byne W. Priorities to Address Gaps in LGBT Health Research. LGBT Health. 2015 Dec;2(4):285-6. doi: 10.1089/lgbt.2015.0129. PubMed PMID: 26788767.

4: Byne W. LGBT Health Equity: Steps Toward Progress and Challenges Ahead. LGBTHealth. 2015 Sep;2(3):193-5. doi: 10.1089/lgbt.2015.0084. Epub 2015 Aug 3. PubMedPMID: 26788667; PubMed Central PMCID: PMC4713022.

5: Dove ES, Barlas IÖ, Birch K, Boehme C, Borda-Rodriguez A, Byne WM, Chaverneff F, Coşkun Y, Dahl ML, Dereli T, Diwakar S, Elbeyli L, Endrenyi L, Eroğlu-Kesim B,Ferguson LR, Güngör K, Gürsoy U, Hekim N, Huzair F, Kaushik K, Kickbusch I,Kıroğlu O, Kolker E, Könönen E, Lin B, Llerena A, Malhan F, Nair B, Patrinos GP, Şardaş S, Sert Ö, Srivastava S, Steuten LM, Toraman C, Vayena E, Wang W, Warnich L, Özdemir V. An Appeal to the Global Health Community for a TripartiteInnovation: An "Essential Diagnostics List," "Health in All Policies," and"See-Through 21(st) Century Science and Ethics". OMICS. 2015 Aug;19(8):435-42.doi: 10.1089/omi.2015.0075. Epub 2015 Jul 10. PubMed PMID: 26161545.

6: Balevich EC, Haznedar MM, Wang E, Newmark RE, Bloom R, Schneiderman JS,Aronowitz J, Tang CY, Chu KW, Byne W, Buchsbaum MS, Hazlett EA. Corpus callosumsize and diffusion tensor anisotropy in adolescents and adults withschizophrenia. Psychiatry Res. 2015 Mar 30;231(3):244-51. doi:10.1016/j.pscychresns.2014.12.005. Epub 2015 Jan 8. PubMed PMID: 25637358; PubMedCentral PMCID: PMC4363270.

7: Reiner W, Byne W. Interview with William Reiner, MD, Urologist and ChildPsychiatrist, on Approaches to Care for Individuals with Disorders of SexDevelopment and Somatic Intersex Conditions. LGBT Health. 2015 Mar;2(1):3-10.doi: 10.1089/lgbt.2015.0008. PubMed PMID: 26790011.

8: Byne W. LGBT Health: Going Strong as We Begin Our Second Year. LGBT Health.2015 Mar;2(1):1-2. doi: 10.1089/lgbt.2015.0010. PubMed PMID: 26790010.

9: Lener MS, Wong E, Tang CY, Byne W, Goldstein KE, Blair NJ, Haznedar MM, NewAS, Chemerinski E, Chu KW, Rimsky LS, Siever LJ, Koenigsberg HW, Hazlett EA.White matter abnormalities in schizophrenia and schizotypal personality disorder.Schizophr Bull. 2015 Jan;41(1):300-10. doi: 10.1093/schbul/sbu093. Epub 2014 Jun 23. PubMed PMID: 24962608; PubMed Central PMCID: PMC4266294.

10: Byne W. The First Year of LGBT Health: A Year of LGBT Progress in the United States. LGBT Health. 2014 Dec;1(4):239-41. doi: 10.1089/lgbt.2014.0085. PubMedPMID: 26789849.

11: Byne W. LGBT Health Disparities, Barriers to Care, Assisted Reproduction,Preexposure Prophylaxis, Electronic Health Records, and Much More. LGBT Health.2014 Sep;1(3):147-8. doi: 10.1089/lgbt.2014.0048. PubMed PMID: 26789704.

12: Byne W. Forty Years After the Removal of Homosexuality from the DSM: Well on the Way but Not There Yet. LGBT Health. 2014 Jun;1(2):67-9. doi:10.1089/lgbt.2014.1504. Epub 2014 Feb 26. PubMed PMID: 26789613.

13: Lutwak N, Byne W, Erickson-Schroth L, Keig Z, Shipherd JC, Mattocks KM, KauthMR. Transgender veterans are inadequately understood by health care providers.Mil Med. 2014 May;179(5):483-5. doi: 10.7205/MILMED-D-14-00001. PubMed PMID:24806492.

14: Byne W, Harvey L. Interview with Leonard Harvey, MD, MBA. LGBT Health. 2014Mar;1(1):3-7. doi: 10.1089/lgbt.2013.1502. Epub 2013 Jul 20. PubMed PMID:26789502.

15: Byne W. A New Era for LGBT Health. LGBT Health. 2014 Mar;1(1):1-2. doi:10.1089/lgbt.2013.1503. PubMed PMID: 26789501.

16: Kozlenkov A, Roussos P, Timashpolsky A, Barbu M, Rudchenko S, Bibikova M,Klotzle B, Byne W, Lyddon R, Di Narzo AF, Hurd YL, Koonin EV, Dracheva S.Differences in DNA methylation between human neuronal and glial cells areconcentrated in enhancers and non-CpG sites. Nucleic Acids Res. 2014Jan;42(1):109-27. doi: 10.1093/nar/gkt838. Epub 2013 Sep 20. PubMed PMID:24057217; PubMed Central PMCID: PMC3874157.

Lisa Dixon 28 of 214 (Total)

http://www.ncbi.nlm.nih.gov/sites/myncbi/1VUX9UpydlrQs/bibliography/47909618/public/?sort=date&direction=ascending

1. Muralidharan A, Lucksted A, Medoff D, Fang LJ, Dixon L. Stigma: a Unique Sourceof Distress for Family Members of Individuals with Mental Illness. The journal ofbehavioral health services & research. 2016; 43(3):484-93. PubMed [journal] PMID:25168187

2. Schiffman J, Lawrence RE, Demro C, Appelbaum PS, Dixon LB. Attitudes towardscannabis use and genetic testing for schizophrenia. Early intervention inpsychiatry. 2016; 10(3):220-6. NIHMSID: NIHMS595143 PubMed [journal] PMID:24957110, PMCID: PMC4275418

3. Record EJ, Medoff DR, Dixon LB, Klingaman EA, Park SG, Hack S, Brown CH, Fang LJ,Kreyenbuhl J. Access to and Use of the Internet by Veterans with Serious MentalIllness. Community mental health journal. 2016; 52(2):136-41. PubMed [journal]PMID: 25821927

4. Pearce MJ, Medoff D, Lawrence RE, Dixon L. Religious Coping Among Adults Caringfor Family Members with Serious Mental Illness. Community mental health journal. 2016; 52(2):194-202. PubMed [journal] PMID: 25895855

5. Katz J, Medoff D, Fang LJ, Dixon LB. The Relationship Between the Perceived Risk of Harm by a Family Member with Mental Illness and the Family Experience.Community mental health journal. 2015; 51(7):790-9. NIHMSID: NIHMS651098 PubMed[journal] PMID: 25535047, PMCID: PMC4478288

6. Klingaman EA, Medoff DR, Park SG, Brown CH, Fang L, Dixon LB, Hack SM, TapscottSL, Walsh MB, Kreyenbuhl JA. Consumer satisfaction with psychiatric services: Therole of shared decision making and the therapeutic relationship. Psychiatricrehabilitation journal. 2015; 38(3):242-8. PubMed [journal] PMID: 25664755

7. Fischer EP, Sherman MD, McSweeney JC, Pyne JM, Owen RR, Dixon LB. Perspectives offamily and veterans on family programs to support reintegration of returningveterans with posttraumatic stress disorder. Psychological services. 2015;12(3):187-98. PubMed [journal] PMID: 26213788

8. Essock SM, Nossel IR, McNamara K, Bennett ME, Buchanan RW, Kreyenbuhl JA, Mendon SJ, Goldman HH, Dixon LB. Practical Monitoring of Treatment Fidelity: ExamplesFrom a Team-Based Intervention for People With Early Psychosis. Psychiatricservices (Washington, D.C.). 2015; 66(7):674-6. NIHMSID: NIHMS673944 PubMed[journal] PMID: 25555176, PMCID: PMC4490109

9. Essock SM, Goldman HH, Hogan MF, Hepburn BM, Sederer LI, Dixon LB. StatePartnerships for First-Episode Psychosis Services. Psychiatric services(Washington, D.C.). 2015; 66(7):671-3. PubMed [journal] PMID: 25555092

10. Dixon LB, Goldman HH, Bennett ME, Wang Y, McNamara KA, Mendon SJ, Goldstein AB,Choi CW, Lee RJ, Lieberman JA, Essock SM. Implementing Coordinated Specialty Carefor Early Psychosis: The RAISE Connection Program. Psychiatric services(Washington, D.C.). 2015; 66(7):691-8. PubMed [journal] PMID: 25772764

11. Lucksted A, Essock SM, Stevenson J, Mendon SJ, Nossel IR, Goldman HH, GoldsteinAB, Dixon LB. Client Views of Engagement in the RAISE Connection Program forEarly Psychosis Recovery. Psychiatric services (Washington, D.C.). 2015;66(7):699-704. NIHMSID: NIHMS695061 PubMed [journal] PMID: 25873029, PMCID:PMC4490071

12. Covell NH, Foster FP, Margolies PJ, Lopez LO, Dixon LB. Using distancetechnologies to facilitate a learning collaborative to implement stagewisetreatment. Psychiatric services (Washington, D.C.). 2015; 66(6):645-8. PubMed[journal] PMID: 25828879

13. Dixon LB, Stroup TS. Medications for first-episode psychosis: making a goodstart. The American journal of psychiatry. 2015; 172(3):209-11. PubMed [journal] PMID: 25727529

14. Marino L, Wissow LS, Davis M, Abrams MT, Dixon LB, Slade EP. Predictors ofoutpatient mental health clinic follow-up after hospitalization amongMedicaid-enrolled young adults. Early intervention in psychiatry. 2015; NIHMSID: NIHMS782688 PubMed [journal] PMID: 25639939, PMCID: PMC4861685

15. Margolies PJ, Broadway-Wilson K, Gregory R, Jewell TC, Scannevin G Jr, Myers RW, Fernandez HA, Ruderman D, McNabb L, Chiang IC, Marino L, Dixon LB. Use oflearning collaboratives by the center for practice innovations to bring IPS toscale in New York State. Psychiatric services (Washington, D.C.). 2015;66(1):4-6. PubMed [journal] PMID: 25321348

16. Smith ME, Lindsey MA, Williams CD, Medoff DR, Lucksted A, Fang LJ, Schiffman J,Lewis-Fernández R, Dixon LB. Race-related differences in the experiences offamily members of persons with mental illness participating in the NAMI Family toFamily Education Program. American journal of community psychology. 2014;54(3-4):316-27. PubMed [journal] PMID: 25213395

17. Park SG, Derman M, Dixon LB, Brown CH, Klingaman EA, Fang LJ, Medoff DR,Kreyenbuhl J. Factors associated with shared decision-making preferences amongveterans with serious mental illness. Psychiatric services (Washington, D.C.).2014; 65(12):1409-13. PubMed [journal] PMID: 25178383

18. Blank MB, Himelhoch SS, Balaji AB, Metzger DS, Dixon LB, Rose CE, Oraka E,Davis-Vogel A, Thompson WW, Heffelfinger JD. A multisite study of the prevalence of HIV with rapid testing in mental health settings. American journal of publichealth. 2014; 104(12):2377-84. NIHMSID: NIHMS589381 PubMed [journal] PMID:24524493, PMCID: PMC4133307

19. First MB, Bhat V, Adler D, Dixon L, Goldman B, Koh S, Levine B, Oslin D, Siris S.How do clinicians actually use the Diagnostic and Statistical Manual of MentalDisorders in clinical practice and why we need to know more. The Journal ofnervous and mental disease. 2014; 202(12):841-4. PubMed [journal] PMID: 25390931

20. Covell NH, Margolies PJ, Myers RW, Ruderman D, Fazio ML, McNabb LM, Gurran S,Thorning H, Watkins L, Dixon LB. Scaling up evidence-based behavioral health carepractices in New York state. Psychiatric services (Washington, D.C.). 2014;65(6):713-5. PubMed [journal] PMID: 24881683

21. Marino LA, Dixon LB. An update on supported employment for people with severemental illness. Current opinion in psychiatry. 2014; 27(3):210-5. PubMed[journal] PMID: 24613982

22. Patel SR, Humensky JL, Olfson M, Simpson HB, Myers R, Dixon LB. Treatment ofobsessive-compulsive disorder in a nationwide survey of office-based physicianpractice. Psychiatric services (Washington, D.C.). 2014; 65(5):681-4. NIHMSID:NIHMS583676 PubMed [journal] PMID: 24585056, PMCID: PMC4051852

23. Slade EP, Wissow LS, Davis M, Abrams MT, Dixon LB. Medicaid lapses and low-incomeyoung adults' receipt of outpatient mental health care after an inpatient stay.Psychiatric services (Washington, D.C.). 2014; 65(4):454-60. NIHMSID: NIHMS552972PubMed [journal] PMID: 24382558, PMCID: PMC3972329

24. Yang LH, Lai GY, Tu M, Luo M, Wonpat-Borja A, Jackson VW, Lewis-Fernández R,Dixon L. A brief anti-stigma intervention for Chinese immigrant caregivers ofindividuals with psychosis: adaptation and initial findings. Transculturalpsychiatry. 2014; 51(2):139-57. NIHMSID: NIHMS569673 PubMed [journal] PMID:24318864, PMCID: PMC3993525

25. Dixon LB, Schwarz EC. Fifty years of progress in community mental health in US:the growth of evidence-based practices. Epidemiology and psychiatric sciences.2014; 23(1):5-9. PubMed [journal] PMID: 24229577

26. Schiffman J, Kline E, Reeves G, Jones A, Medoff D, Lucksted A, Fang LJ, Dixon LB.Differences between parents of young versus adult children seeking to participatein family-to-family psychoeducation. Psychiatric services (Washington, D.C.).2014; 65(2):247-50. NIHMSID: NIHMS728450 PubMed [journal] PMID: 24492901, PMCID: PMC4727965

27. Xiang YT, Li LJ, Zhou JJ, Wang CY, Dixon LB, Dickerson F, Zhou FC, Ungvari GS,Zhang XY, Shum DH, Au RW, Tang WK, Man D, Chiu HF. Quality of life of patientswith euthymic bipolar disorder and its associations with demographic and clinicalcharacteristics, psychopathology, and cognitive deficits. Perspectives inpsychiatric care. 2014; 50(1):44-50. PubMed [journal] PMID: 24308864

28. Dixon LB, Glynn SM, Cohen AN, Drapalski AL, Medoff D, Fang LJ, Potts W, Gioia D. Outcomes of a brief program, REORDER, to promote consumer recovery and familyinvolvement in care. Psychiatric services (Washington, D.C.). 2014; 65(1):116-20.PubMed [journal] PMID: 24177229

Stella Dracheva 7 of 62 (Total)

http://www.ncbi.nlm.nih.gov/sites/myncbi/1Bstsc__85aAp/bibliography/47280994/public/?sort=date&direction=ascending 

1. Kozlenkov A, Wang M, Roussos P, Rudchenko S, Barbu M, Bibikova M, Klotzle B,Dwork AJ, Zhang B, Hurd YL, Koonin EV, Wegner M, Dracheva S. Substantial DNAmethylation differences between two major neuronal subtypes in human brain.Nucleic acids research. 2016; 44(6):2593-61 2. PubMed [journal] PMID: 26612861,PMCID: PMC4824074

2. Lu AT, Hannon E, Levine ME, Hao K, Crimmins EM, Lunnon K, Kozlenkov A, Mill J, Dracheva S, Horvath S. Genetic variants near MLST8 and DHX57 affect theepigenetic age of the cerebellum. Nature communications. 2016; 7:10561. PubMed[journal] PMID: 26830004, PMCID: PMC4740877

3. Halene TB, Kozlenkov A, Jiang Y, Mitchell AC, Javidfar B, Dincer A, Park R,Wiseman J, Croxson PL, Giannaris EL, Hof PR, Roussos P, Dracheva S, Hemby SE,Akbarian S. NeuN+ neuronal nuclei in non-human primate prefrontal cortex andsubcortical white matter after clozapine exposure. Schizophrenia research. 2016; 170(2-3):235-44. NIHMSID: NIHMS750072 PubMed [journal] PMID: 26776227, PMCID:PMC4740223

4. Akbarian S, Liu C, Knowles JA, Vaccarino FM, Farnham PJ, Crawford GE, Jaffe AE,Pinto D, Dracheva S, Geschwind DH, Mill J, Nairn AC, Abyzov A, Pochareddy S,Prabhakar S, Weissman S, Sullivan PF, State MW, Weng Z, Peters MA, White KP,Gerstein MB, Amiri A, Armoskus C, Ashley-Koch AE, Bae T, Beckel-Mitchener A,Berman BP, Coetzee GA, Coppola G, Francoeur N, Fromer M, Gao R, Grennan K,Herstein J, Kavanagh DH, Ivanov NA, Jiang Y, Kitchen RR, Kozlenkov A, Kundakovic M, Li M, Li Z, Liu S, Mangravite LM, Mattei E, Markenscoff-Papadimitriou E,Navarro FC, North N, Omberg L, Panchision D, Parikshak N, Poschmann J, Price AJ, Purcaro M, Reddy TE, Roussos P, Schreiner S, Scuderi S, Sebra R, Shibata M, ShiehAW, Skarica M, Sun W, Swarup V, Thomas A, Tsuji J, van Bakel H, Wang D, Wang Y,Wang K, Werling DM, Willsey AJ, Witt H, Won H, Wong CC, Wray GA, Wu EY, Xu X, YaoL, Senthil G, Lehner T, Sklar P, Sestan N. The PsychENCODE project. Natureneuroscience. 2015; 18(12):1707-12. NIHMSID: NIHMS741465 PubMed [journal] PMID:26605881, PMCID: PMC4675669

5. Di Narzo AF, Kozlenkov A, Ge Y, Zhang B, Sanelli L, May Z, Li Y, Fouad K, CardozoC, Koonin EV, Bennett DJ, Dracheva S. Decrease of mRNA Editing after Spinal Cord Injury is Caused by Down-regulation of ADAR2 that is Triggered by InflammatoryResponse. Scientific reports. 2015; 5:12615. PubMed [journal] PMID: 26223940,PMCID: PMC4519770

6. Di Narzo AF, Kozlenkov A, Roussos P, Hao K, Hurd Y, Lewis DA, Sibille E, SieverLJ, Koonin E, Dracheva S. A unique gene expression signature associated withserotonin 2C receptor RNA editing in the prefrontal cortex and altered insuicide. Human molecular genetics. 2014; 23(18):4801-13. PubMed [journal] PMID:24781207, PMCID: PMC4140462

7. Kozlenkov A, Roussos P, Timashpolsky A, Barbu M, Rudchenko S, Bibikova M, KlotzleB, Byne W, Lyddon R, Di Narzo AF, Hurd YL, Koonin EV, Dracheva S. Differences in DNA methylation between human neuronal and glial cells are concentrated inenhancers and non-CpG sites. Nucleic acids research. 2014; 42(1):109-27. PubMed[journal] PMID: 24057217, PMCID: PMC3874157

Marianne Goodman 3 of 46 (Total)

1. Denny BT, Fan J, Liu X, Ochsner KN, Guerreri S, Mayson SJ, Rimsky L, McMaster A, New AS, Goodman M, Siever LJ, Koenigsberg HW. Elevated amygdala activity duringreappraisal anticipation predicts anxiety in avoidant personality disorder.Journal of affective disorders. 2015; 172:1-7. PubMed [journal] PMID: 25451388

2. Goodman M, Carpenter D, Tang CY, Goldstein KE, Avedon J, Fernandez N, Mascitelli KA, Blair NJ, New AS, Triebwasser J, Siever LJ, Hazlett EA. Dialectical behavior therapy alters emotion regulation and amygdala activity in patients withborderline personality disorder. Journal of psychiatric research. 2014;57:108-16. NIHMSID: NIHMS646634 PubMed [journal] PMID: 25038629, PMCID:PMC4263347

3. Koenigsberg HW, Denny BT, Fan J, Liu X, Guerreri S, Mayson SJ, Rimsky L, New AS, Goodman M, Siever LJ. The neural correlates of anomalous habituation to negative emotional pictures in borderline and avoidant personality disorder patients. The American journal of psychiatry. 2014; 171(1):82-90. NIHMSID: NIHMS520789 PubMed[journal] PMID: 24275960, PMCID: PMC3947284

 

Tobias Halene 4 of 27 (Total)

http://www.ncbi.nlm.nih.gov/sites/myncbi/1bacsQUKn6hQm/bibliography/44256264/public/?sort=date&direction=descending

 

1: Fullard JF, Halene TB, Giambartolomei C, Haroutunian V, Akbarian S, Roussos P.Understanding the genetic liability to schizophrenia through the neuroepigenome. Schizophr Res. 2016 Jan 27. pii: S0920-9964(16)30039-1. doi:10.1016/j.schres.2016.01.039. [Epub ahead of print] Review. PubMed PMID:26827128; PubMed Central PMCID: PMC4963306.

2: Halene TB, Kozlenkov A, Jiang Y, Mitchell AC, Javidfar B, Dincer A, Park R,Wiseman J, Croxson PL, Giannaris EL, Hof PR, Roussos P, Dracheva S, Hemby SE,Akbarian S. NeuN+ neuronal nuclei in non-human primate prefrontal cortex andsubcortical white matter after clozapine exposure. Schizophr Res. 2016Feb;170(2-3):235-44. doi: 10.1016/j.schres.2015.12.016. Epub 2016 Jan 6. PubMedPMID: 26776227; PubMed Central PMCID: PMC4740223.

3: Halene TB, Peter CJ, Akbarian S. Epigenetic Dysregulation in the Schizophrenic Brain. Curr Behav Neurosci Rep. 1.2 (2014): 86-93.

4: Maze I, Wenderski W, Noh KM, Bagot RC, Tzavaras N, Purushothaman I, Elsässer SJ, Guo Y, Ionete C, Hurd YL, Tamminga CA, Halene TB, Farrelly L, Wen D, Rafii S, Birtwistle MR, Akbarian S, Buchholz BA, Blitzer RD, Nestler EJ, Shen L, Molina H, Allis CD. Critical Role of Histone Turnover in Mammalian Transcription and Neuronal Function. Neuron. Accepted.

 

Vahram Haroutunian 35 of 297 (Total)

http://www.ncbi.nlm.nih.gov/sites/myncbi/16_1oNJuyK9QS/bibliography/44613971/public/?sort=date&direction=ascending

1: McCullumsmith RE, O'Donovan SM, Drummond JB, Benesh FS, Simmons M, Roberts R, Lauriat T, Haroutunian V, Meador-Woodruff JH. Shaping plasticity: Alterations in glutamate transporter localization as a pathophysiological mechanism in severemental illness. Mol Psychiatry. 2016 Jun;21(6):723. doi: 10.1038/mp.2016.79.PubMed PMID: 27198660.

2: Scheckel C, Drapeau E, Frias MA, Park CY, Fak J, Zucker-Scharff I, Kou Y,Haroutunian V, Ma'ayan A, Buxbaum JD, Darnell RB. Regulatory consequences ofneuronal ELAV-like protein binding to coding and non-coding RNAs in human brain. Elife. 2016 Feb 19;5. pii: e10421. doi: 10.7554/eLife.10421. PubMed PMID:26894958; PubMed Central PMCID: PMC4798961.

3: Pinner AL, Tucholski J, Haroutunian V, McCullumsmith RE, Meador-Woodruff JH.Decreased protein S-palmitoylation in dorsolateral prefrontal cortex inschizophrenia. Schizophr Res. 2016 Feb 11. pii: S0920-9964(16)30055-X. doi:10.1016/j.schres.2016.01.054. [Epub ahead of print] PubMed PMID: 26876311; PubMedCentral PMCID: PMC4981568.

4: Fullard JF, Halene TB, Giambartolomei C, Haroutunian V, Akbarian S, Roussos P.Understanding the genetic liability to schizophrenia through the neuroepigenome. Schizophr Res. 2016 Jan 27. pii: S0920-9964(16)30039-1. doi:10.1016/j.schres.2016.01.039. [Epub ahead of print] Review. PubMed PMID:26827128; PubMed Central PMCID: PMC4963306.

5: Watson CT, Roussos P, Garg P, Ho DJ, Azam N, Katsel PL, Haroutunian V, SharpAJ. Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer's disease. Genome Med. 2016 Jan19;8(1):5. doi: 10.1186/s13073-015-0258-8. PubMed PMID: 26803900; PubMed Central PMCID: PMC4719699.

6: Fá M, Puzzo D, Piacentini R, Staniszewski A, Zhang H, Baltrons MA, Li Puma DD,Chatterjee I, Li J, Saeed F, Berman HL, Ripoli C, Gulisano W, Gonzalez J, Tian H,Costa JA, Lopez P, Davidowitz E, Yu WH, Haroutunian V, Brown LM, Palmeri A,Sigurdsson EM, Duff KE, Teich AF, Honig LS, Sierks M, Moe JG, D'Adamio L, Grassi C, Kanaan NM, Fraser PE, Arancio O. Extracellular Tau Oligomers Produce AnImmediate Impairment of LTP and Memory. Sci Rep. 2016 Jan 20;6:19393. doi:10.1038/srep19393. PubMed PMID: 26786552; PubMed Central PMCID: PMC4726138.

7: Readhead B, Haure-Mirande JV, Zhang B, Haroutunian V, Gandy S, Schadt EE,Dudley JT, Ehrlich ME. Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies sharedfeatures with human Alzheimer's brain molecular pathology. Mol Psychiatry. 2016Aug;21(8):1153-4. doi: 10.1038/mp.2015.215. Epub 2016 Jan 19. PubMed PMID:26782051.

8: Bhambhvani HP, Simmons M, Haroutunian V, Meador-Woodruff JH. Decreasedexpression of cortactin in the schizophrenia brain. Neuroreport. 2016 Feb10;27(3):145-50. doi: 10.1097/WNR.0000000000000514. PubMed PMID: 26691754; PubMedCentral PMCID: PMC4733612.

9: Readhead B, Haure-Mirande JV, Zhang B, Haroutunian V, Gandy S, Schadt EE,Dudley JT, Ehrlich ME. Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies sharedfeatures with human Alzheimer's brain molecular pathology. Mol Psychiatry. 2016Aug;21(8):1099-111. doi: 10.1038/mp.2015.167. Epub 2015 Nov 10. PubMed PMID:26552589; PubMed Central PMCID: PMC4862938.

10: McCullumsmith RE, O'Donovan SM, Drummond JB, Benesh FS, Simmons M, Roberts R,Lauriat T, Haroutunian V, Meador-Woodruff JH. Cell-specific abnormalities ofglutamate transporters in schizophrenia: sick astrocytes and compensating relayneurons? Mol Psychiatry. 2016 Jun;21(6):823-30. doi: 10.1038/mp.2015.148. Epub2015 Sep 29. PubMed PMID: 26416546.

11: Zhu L, Zhong M, Elder GA, Sano M, Holtzman DM, Gandy S, Cardozo C,Haroutunian V, Robakis NK, Cai D. Phospholipid dysregulation contributes toApoE4-associated cognitive deficits in Alzheimer's disease pathogenesis. ProcNatl Acad Sci U S A. 2015 Sep 22;112(38):11965-70. doi: 10.1073/pnas.1510011112. Epub 2015 Sep 8. PubMed PMID: 26372964; PubMed Central PMCID: PMC4586834.

12: Mueller TM, Remedies CE, Haroutunian V, Meador-Woodruff JH. Abnormalsubcellular localization of GABAA receptor subunits in schizophrenia brain.Transl Psychiatry. 2015 Aug 4;5:e612. doi: 10.1038/tp.2015.102. PubMed PMID:26241350; PubMed Central PMCID: PMC4564557.

13: Scott MR, Rubio MD, Haroutunian V, Meador-Woodruff JH. Protein Expression of Proteasome Subunits in Elderly Patients with Schizophrenia.Neuropsychopharmacology. 2016 Feb;41(3):896-905. doi: 10.1038/npp.2015.219. Epub 2015 Jul 23. PubMed PMID: 26202105; PubMed Central PMCID: PMC4707836.

14: Kippe JM, Mueller TM, Haroutunian V, Meador-Woodruff JH. AbnormalN-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia.Schizophr Res. 2015 Aug;166(1-3):219-24. doi: 10.1016/j.schres.2015.06.002. Epub 2015 Jun 20. PubMed PMID: 26104473; PubMed Central PMCID: PMC4512847.15: O'Donovan SM, Hasselfeld K, Bauer D, Simmons M, Roussos P, Haroutunian V,Meador-Woodruff JH, McCullumsmith RE. Glutamate transporter splice variantexpression in an enriched pyramidal cell population in schizophrenia. TranslPsychiatry. 2015 Jun 9;5:e579. doi: 10.1038/tp.2015.74. PubMed PMID: 26057049;PubMed Central PMCID: PMC4490284.

16: Sullivan CR, Funk AJ, Shan D, Haroutunian V, McCullumsmith RE. Decreasedchloride channel expression in the dorsolateral prefrontal cortex inschizophrenia. PLoS One. 2015 Mar 31;10(3):e0123158. doi:10.1371/journal.pone.0123158. eCollection 2015. PubMed PMID: 25826365; PubMedCentral PMCID: PMC4380350.

17: Zhao W, Wang J, Varghese M, Ho L, Mazzola P, Haroutunian V, Katsel PL, GibsonGE, Levine S, Dubner L, Pasinetti GM. Impaired mitochondrial energy metabolism asa novel risk factor for selective onset and progression of dementia in oldest-oldsubjects. Neuropsychiatr Dis Treat. 2015 Mar 5;11:565-74. doi:10.2147/NDT.S74898. eCollection 2015. PubMed PMID: 25784811; PubMed CentralPMCID: PMC4356684.

18: Hertzberg L, Katsel P, Roussos P, Haroutunian V, Domany E. Integration ofgene expression and GWAS results supports involvement of calcium signaling inSchizophrenia. Schizophr Res. 2015 May;164(1-3):92-9. doi:10.1016/j.schres.2015.02.001. Epub 2015 Feb 20. PubMed PMID: 25702973.

19: Bristow GC, Bostrom JA, Haroutunian V, Sodhi MS. Sex differences in GABAergicgene expression occur in the anterior cingulate cortex in schizophrenia.Schizophr Res. 2015 Sep;167(1-3):57-63. doi: 10.1016/j.schres.2015.01.025. Epub2015 Feb 7. PubMed PMID: 25660468; PubMed Central PMCID: PMC4524801.

20: Tsang J, Fullard JF, Giakoumaki SG, Katsel P, Eirini Karagiorga V, Greenwood TA, Braff DL, Siever LJ, Bitsios P, Haroutunian V, Roussos P. Erratum: Therelationship between dopamine receptor D1 and cognitive performance. NPJSchizophr. 2015 Jun 10;1:15018. doi: 10.1038/npjschz.2015.18. eCollection 2015.PubMed PMID: 27336628; PubMed Central PMCID: PMC4849446.

21: Tsang J, Fullard JF, Giakoumaki SG, Katsel P, Katsel P, Karagiorga VE,Greenwood TA, Braff DL, Siever LJ, Bitsios P, Haroutunian V, Roussos P. Therelationship between dopamine receptor D1 and cognitive performance. NPJSchizophr. 2015 Mar 4;1:14002. doi: 10.1038/npjschz.2014.2. eCollection 2015.Erratum in: NPJ Schizophr. 2015;1:15018. PubMed PMID: 27336024; PubMed CentralPMCID: PMC4849437.

22: Roussos P, Katsel P, Fam P, Tan W, Purohit DP, Haroutunian V. The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhancedinflammation, neuropathological lesions and increased risk for Alzheimer'sdementia. Alzheimers Dement. 2015 Oct;11(10):1163-70. doi:10.1016/j.jalz.2014.10.013. Epub 2014 Dec 9. PubMed PMID: 25499537; PubMedCentral PMCID: PMC4461564.

23: Bharadwaj R, Peter CJ, Jiang Y, Roussos P, Vogel-Ciernia A, Shen EY, MitchellAC, Mao W, Whittle C, Dincer A, Jakovcevski M, Pothula V, Rasmussen TP,Giakoumaki SG, Bitsios P, Sherif A, Gardner PD, Ernst P, Ghose S, Sklar P, Haroutunian V, Tamminga C, Myers RH, Futai K, Wood MA, Akbarian S. Conservedhigher-order chromatin regulates NMDA receptor gene expression and cognition.Neuron. 2014 Dec 3;84(5):997-1008. doi: 10.1016/j.neuron.2014.10.032. Epub 2014Nov 13. PubMed PMID: 25467983; PubMed Central PMCID: PMC4258154.

24: Funk AJ, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE. Increased Gprotein-coupled receptor kinase (GRK) expression in the anterior cingulate cortexin schizophrenia. Schizophr Res. 2014 Oct;159(1):130-5. doi:10.1016/j.schres.2014.07.040. Epub 2014 Aug 19. PubMed PMID: 25153362; PubMedCentral PMCID: PMC4177355.

25: Lunnon K, Smith R, Hannon E, De Jager PL, Srivastava G, Volta M, Troakes C,Al-Sarraj S, Burrage J, Macdonald R, Condliffe D, Harries LW, Katsel P,Haroutunian V, Kaminsky Z, Joachim C, Powell J, Lovestone S, Bennett DA,Schalkwyk LC, Mill J. Methylomic profiling implicates cortical deregulation ofANK1 in Alzheimer's disease. Nat Neurosci. 2014 Sep;17(9):1164-70. doi:10.1038/nn.3782. Epub 2014 Aug 17. PubMed PMID: 25129077; PubMed Central PMCID:PMC4410018.

26: Simon RA, Shirani H, Aslund KO, Bäck M, Haroutunian V, Gandy S, Nilsson KP.Pentameric thiophene-based ligands that spectrally discriminate amyloid-β and tauaggregates display distinct solvatochromism and viscosity-induced spectralshifts. Chemistry. 2014 Sep 22;20(39):12537-43. doi: 10.1002/chem.201402890. Epub2014 Aug 8. PubMed PMID: 25111601; PubMed Central PMCID: PMC4221846.

27: Haroutunian V, Katsel P, Roussos P, Davis KL, Altshuler LL, Bartzokis G.Myelination, oligodendrocytes, and serious mental illness. Glia. 2014Nov;62(11):1856-77. doi: 10.1002/glia.22716. Epub 2014 Jul 23. Review. PubMedPMID: 25056210.

28: Jun G, Asai H, Zeldich E, Drapeau E, Chen C, Chung J, Park JH, Kim S,Haroutunian V, Foroud T, Kuwano R, Haines JL, Pericak-Vance MA, Schellenberg GD, Lunetta KL, Kim JW, Buxbaum JD, Mayeux R, Ikezu T, Abraham CR, Farrer LA. PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation. AnnNeurol. 2014 Sep;76(3):379-92. doi: 10.1002/ana.24219. Epub 2014 Jul 29. PubMedPMID: 25043464; PubMed Central PMCID: PMC4830273.

29: McGuire JL, Hammond JH, Yates SD, Chen D, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE. Altered serine/threonine kinase activity in schizophrenia.Brain Res. 2014 Jun 3;1568:42-54. doi: 10.1016/j.brainres.2014.04.029. Epub 2014 Apr 26. PubMed PMID: 24780530; PubMed Central PMCID: PMC4096904.

30: Lubitz I, Haroutunian V, Katsel P, Leroith D, Landa N, Castel D, Shaish A,Shnerb R, Schnaider-Beeri M. Non-viability of crossing the Alzheimer mouse model Tg2576 with the type 2 diabetes mouse model ob/ob. Neurobiol Aging. 2014Jul;35(7):e19-20. doi: 10.1016/j.neurobiolaging.2014.01.138. Epub 2014 Jan 31.PubMed PMID: 24581479.

31: Pinner AL, Haroutunian V, Meador-Woodruff JH. Alterations of themyristoylated, alanine-rich C kinase substrate (MARCKS) in prefrontal cortex inschizophrenia. Schizophr Res. 2014 Apr;154(1-3):36-41. doi:10.1016/j.schres.2014.02.003. Epub 2014 Feb 22. PubMed PMID: 24568864; PubMedCentral PMCID: PMC3999918.

32: Shan D, Mount D, Moore S, Haroutunian V, Meador-Woodruff JH, McCullumsmithRE. Abnormal partitioning of hexokinase 1 suggests disruption of a glutamatetransport protein complex in schizophrenia. Schizophr Res. 2014Apr;154(1-3):1-13. doi: 10.1016/j.schres.2014.01.028. Epub 2014 Feb 21. PubMedPMID: 24560881; PubMed Central PMCID: PMC4151500.

33: Roussos P, Haroutunian V. Schizophrenia: susceptibility genes andoligodendroglial and myelin related abnormalities. Front Cell Neurosci. 2014 Jan 21;8:5. doi: 10.3389/fncel.2014.00005. eCollection 2014. Review. PubMed PMID:24478629; PubMed Central PMCID: PMC3896818.

34: Huynh JL, Garg P, Thin TH, Yoo S, Dutta R, Trapp BD, Haroutunian V, Zhu J,Donovan MJ, Sharp AJ, Casaccia P. Epigenome-wide differences in pathology-freeregions of multiple sclerosis-affected brains. Nat Neurosci. 2014Jan;17(1):121-30. doi: 10.1038/nn.3588. Epub 2013 Nov 24. PubMed PMID: 24270187; PubMed Central PMCID: PMC3934491.

35: Mueller TM, Haroutunian V, Meador-Woodruff JH. N-Glycosylation of GABAAreceptor subunits is altered in Schizophrenia. Neuropsychopharmacology. 2014Feb;39(3):528-37. doi: 10.1038/npp.2013.190. Epub 2013 Aug 6. PubMed PMID:23917429; PubMed Central PMCID: PMC3895232.

Hazlett 12 of 123 (Total)

http://www.ncbi.nlm.nih.gov/sites/myncbi/10C-rZHWcrxAp/bibliograpahy/48206726/public/?sort=date&direction=descending

1: Hazlett EA, Blair NJ, Fernandez N, Mascitelli K, Perez-Rodriguez MM, New AS,Goetz RR, Goodman M. Startle amplitude during unpleasant pictures is greater inveterans with a history of multiple-suicide attempts and predicts a futuresuicide attempt. Psychophysiology. 2016 Jul 5. doi: 10.1111/psyp.12698. [Epubahead of print] PubMed PMID: 27378071.

2: Hazlett EA. Neural Substrates of Emotion-Processing Abnormalities inBorderline Personality Disorder. Biol Psychiatry. 2016 Jan 15;79(2):74-5. doi:10.1016/j.biopsych.2015.10.008. PubMed PMID: 26674587.

3: Bralet MC, Buchsbaum MS, DeCastro A, Hazlett EA, Mehmet Haznedar M,Shihabuddin L, Mitelman SA. Erratum to: FDG-PET scans in patients withKraepelinian and non-Kraepelinian schizophrenia. Eur Arch Psychiatry ClinNeurosci. 2016 Jun;266(4):379. PubMed PMID: 26620489.

4: Sher L, Siever LJ, Goodman M, McNamara M, Hazlett EA, Koenigsberg HW, New AS. Gender differences in the clinical characteristics and psychiatric comorbidity inpatients with antisocial personality disorder. Psychiatry Res. 2015 Oct30;229(3):685-9. doi: 10.1016/j.psychres.2015.08.022. Epub 2015 Aug 12. PubMedPMID: 26296756.

5: Balevich EC, Haznedar MM, Wang E, Newmark RE, Bloom R, Schneiderman JS,Aronowitz J, Tang CY, Chu KW, Byne W, Buchsbaum MS, Hazlett EA. Corpus callosumsize and diffusion tensor anisotropy in adolescents and adults withschizophrenia. Psychiatry Res. 2015 Mar 30;231(3):244-51. doi:10.1016/j.pscychresns.2014.12.005. Epub 2015 Jan 8. PubMed PMID: 25637358; PubMedCentral PMCID: PMC4363270.

6: Hazlett EA, Rothstein EG, Ferreira R, Silverman JM, Siever LJ, Olincy A.Sensory gating disturbances in the spectrum: similarities and differences inschizotypal personality disorder and schizophrenia. Schizophr Res. 2015Feb;161(2-3):283-90. doi: 10.1016/j.schres.2014.11.020. Epub 2014 Dec 5. PubMedPMID: 25482574; PubMed Central PMCID: PMC4308515.

7: Rosell DR, Zaluda LC, McClure MM, Perez-Rodriguez MM, Strike KS, Barch DM,Harvey PD, Girgis RR, Hazlett EA, Mailman RB, Abi-Dargham A, Lieberman JA, SieverLJ. Effects of the D1 dopamine receptor agonist dihydrexidine (DAR-0100A) onworking memory in schizotypal personality disorder. Neuropsychopharmacology. 2015Jan;40(2):446-53. doi: 10.1038/npp.2014.192. Epub 2014 Jul 30. PubMed PMID:25074637; PubMed Central PMCID: PMC4443959.

8: Goodman M, Carpenter D, Tang CY, Goldstein KE, Avedon J, Fernandez N,Mascitelli KA, Blair NJ, New AS, Triebwasser J, Siever LJ, Hazlett EA.Dialectical behavior therapy alters emotion regulation and amygdala activity inpatients with borderline personality disorder. J Psychiatr Res. 2014Oct;57:108-16. doi: 10.1016/j.jpsychires.2014.06.020. Epub 2014 Jul 2. PubMedPMID: 25038629; PubMed Central PMCID: PMC4263347.

9: Lener MS, Wong E, Tang CY, Byne W, Goldstein KE, Blair NJ, Haznedar MM, NewAS, Chemerinski E, Chu KW, Rimsky LS, Siever LJ, Koenigsberg HW, Hazlett EA.White matter abnormalities in schizophrenia and schizotypal personality disorder.Schizophr Bull. 2015 Jan;41(1):300-10. doi: 10.1093/schbul/sbu093. Epub 2014 Jun 23. PubMed PMID: 24962608; PubMed Central PMCID: PMC4266294.

10: Thompson JL, Rosell DR, Slifstein M, Girgis RR, Xu X, Ehrlich Y, Kegeles LS, Hazlett EA, Abi-Dargham A, Siever LJ. Prefrontal dopamine D1 receptors andworking memory in schizotypal personality disorder: a PET study with [¹¹C]NNC112.Psychopharmacology (Berl). 2014 Oct;231(21):4231-40. doi:10.1007/s00213-014-3566-6. Epub 2014 Apr 30. PubMed PMID: 24781514; PubMedCentral PMCID: PMC4194223.

11: Hazlett EA, Lamade RV, Graff FS, McClure MM, Kolaitis JC, Goldstein KE,Siever LJ, Godbold JH, Moshier E. Visual-spatial working memory performance andtemporal gray matter volume predict schizotypal personality disorder groupmembership. Schizophr Res. 2014 Feb;152(2-3):350-7. doi:10.1016/j.schres.2013.12.006. Epub 2014 Jan 4. PubMed PMID: 24398009.

12: Zhang J, Buchsbaum MS, Chu KW, Hazlett EA. A manual, semi-automated andautomated ROI study of fMRI hemodynamic response. Stud Health Technol Inform.2013;192:921. PubMed PMID: 23920695.

Sharat Iyer 5 of 14 (Total)

1. Iyer SP, Spaeth-Rublee B, Pincus HA. Challenges in the Operationalization ofMental Health Quality Measures: An Assessment of Alternatives. Psychiatricservices (Washington, D.C.). 2016; :appips201600198. PubMed [journal] PMID:27301768

2. Iyer SP, Pancake LS, Dandino ES, Wells KB. Consumer-Involved ParticipatoryResearch to Address General Medical Health and Wellness in a Community MentalHealth Setting. Psychiatric services (Washington, D.C.). 2015; 66(12):1268-70.PubMed [journal] PMID: 26174950

3. Iyer SP, Jones A, Talamantes E, Barnert ES, Kanzaria HK, Detz A, Daskivich TJ,Jones L, Ryan GW, Mahajan AP. Improving Health Care for the Future Uninsured inLos Angeles County: A Community-Partnered Dialogue. Ethnicity & disease. 2015;25(4):487-94. PubMed [journal] PMID: 26675541, PMCID: PMC4671431

4. Parameswaran SG, Spaeth-Rublee B, Pincus HA. Measuring the quality of mentalhealth care: consensus perspectives from selected industrialized countries.Administration and policy in mental health. 2015; 42(3):288-95. PubMed [journal] PMID: 24951953

5. Iyer SP, Young AS. Health screening, counseling, and hypertension control forpeople with serious mental illness at primary care visits. General hospitalpsychiatry. 2015; 37(1):60-6. PubMed [journal] PMID: 25480463

Deborah Kayman 1 of 8 (Total)

1: Kayman DJ, Goldstein MF, Dixon L, Goodman M. Perspectives of Suicidal Veterans on Safety Planning: Findings From a Pilot Study. Crisis. 2015;36(5):371-83. doi: 10.1027/0227-5910/a000348. PubMed PMID: 26502788.

Yulia Landa 7 of 13 (Total)

http://www.ncbi.nlm.nih.gov/pubmed/?term=landa+yulia

1: Perez DL, Pan H, Weisholtz DS, Root JC, Tuescher O, Fischer DB, Butler T, VagoDR, Isenberg N, Epstein J, Landa Y, Smith TE, Savitz AJ, Silbersweig DA, Stern E.Altered threat and safety neural processing linked to persecutory delusions inschizophrenia: a two-task fMRI study. Psychiatry Res. 2015 Sep 30;233(3):352-66. doi: 10.1016/j.pscychresns.2015.06.002. Epub 2015 Jun 23. PubMed PMID: 26208746.

2: Reyna VF, Landa Y. Multiple traces or Fuzzy Traces? Converging evidence forapplications of modern cognitive theory to psychotherapy. Behav Brain Sci.2015;38:e22. doi: 10.1017/S0140525X14000399. PubMed PMID: 26050686.

3: Loughland C, Cheng K, Harris G, Kelly B, Cohen M, Sandhu H, Varmos M, LevinTT, Bylund C, Landa Y, Outram S. Communication of a schizophrenia diagnosis: Aqualitative study of patients' perspectives. Int J Soc Psychiatry. 2015Dec;61(8):729-34. doi: 10.1177/0020764015576814. Epub 2015 Apr 1. PubMed PMID:25834281.

4: Landa Y, Mueser KT, Wyka KE, Shreck E, Jespersen R, Jacobs MA, Griffin KW, vander Gaag M, Reyna VF, Beck AT, Silbersweig DA, Walkup JT. Development of a group and family-based cognitive behavioural therapy program for youth at risk forpsychosis. Early Interv Psychiatry. 2015 Jan 13. doi: 10.1111/eip.12204. [Epubahead of print] PubMed PMID: 25585830.

5: Outram S, Harris G, Kelly B, Cohen M, Bylund CL, Landa Y, Levin TT, Sandhu H, Vamos M, Loughland C. Contextual barriers to discussing a schizophrenia diagnosiswith patients and families: need for leadership and teamwork training inpsychiatry. Acad Psychiatry. 2015 Apr;39(2):174-80. doi:10.1007/s40596-014-0226-4. Epub 2014 Nov 15. PubMed PMID: 25398264.

6: Outram S, Harris G, Kelly B, Bylund CL, Cohen M, Landa Y, Levin T, Sandhu H,Vamos M, Loughland C. 'We didn't have a clue': Family caregivers' experiences of the communication of a diagnosis of schizophrenia. Int J Soc Psychiatry. 2015Feb;61(1):10-6. doi: 10.1177/0020764014535751. Epub 2014 May 27. PubMed PMID:24869849.

7: Outram S, Harris G, Kelly B, Cohen M, Sandhu H, Vamos M, Levin TT, Landa Y,Bylund-Lincoln CL, Loughland C. Communicating a schizophrenia diagnosis topatients and families: a qualitative study of mental health clinicians. PsychiatrServ. 2014 Apr 1;65(4):551-4. doi: 10.1176/appi.ps.201300202. PubMed PMID:24687107.

Deborah Perlick 2 of 32 (Total)

1: Perlick DA, Berk L, Kaczynski R, Gonzalez J, Link B, Dixon L, Grier S,Miklowitz DJ. Caregiver burden as a predictor of depression among family andfriends who provide care for persons with bipolar disorder. Bipolar Disord. 2016 Mar;18(2):183-91. doi: 10.1111/bdi.12379. Epub 2016 Mar 23. PubMed PMID:27004622.

2: Corrigan PW, Druss BG, Perlick DA. The Impact of Mental Illness Stigma onSeeking and Participating in Mental Health Care. Psychol Sci Public Interest.2014 Oct;15(2):37-70. doi: 10.1177/1529100614531398. PubMed PMID: 26171956.

Panagiotis Roussos 39 of 72 (Total)

http://bit.ly/1UalkgT

1. Roussos P, Giakoumaki SG, Zouraraki C, Fullard JF, Karagiorga VE, Tsapakis EM,Petraki Z, Siever LJ, Lencz T, Malhotra A, Spanaki C, Bitsios P. The Relationshipof Common Risk Variants and Polygenic Risk for Schizophrenia to SensorimotorGating. Biological psychiatry. 2016; 79(12):988-96. PubMed [journal] PMID:26212897

2. Howrigan DP, Simonson MA, Davies G, Harris SE, Tenesa A, Starr JM, Liewald DC,Deary IJ, McRae A, Wright MJ, Montgomery GW, Hansell N, Martin NG, Payton A,Horan M, Ollier WE, Abdellaoui A, Boomsma DI, DeRosse P, Knowles EE, Glahn DC,Djurovic S, Melle I, Andreassen OA, Christoforou A, Steen VM, Hellard SL, Sundet K, Reinvang I, Espeseth T, Lundervold AJ, Giegling I, Konte B, Hartmann AM,Rujescu D, Roussos P, Giakoumaki S, Burdick KE, Bitsios P, Donohoe G, Corley RP, Visscher PM, Pendleton N, Malhotra AK, Neale BM, Lencz T, Keller MC. Genome-wide autozygosity is associated with lower general cognitive ability. Molecularpsychiatry. 2016; 21(6):837-43. NIHMSID: NIHMS743617 PubMed [journal] PMID:26390830, PMCID: PMC4803638

3. Kozlenkov A, Wang M, Roussos P, Rudchenko S, Barbu M, Bibikova M, Klotzle B,Dwork AJ, Zhang B, Hurd YL, Koonin EV, Wegner M, Dracheva S. Substantial DNAmethylation differences between two major neuronal subtypes in human brain.Nucleic acids research. 2016; 44(6):2593-612. PubMed [journal] PMID: 26612861,PMCID: PMC4824074

4. Hauberg ME, Roussos P, Grove J, Børglum AD, Mattheisen M. Analyzing the Role ofMicroRNAs in Schizophrenia in the Context of Common Genetic Risk Variants. JAMApsychiatry. 2016; 73(4):369-77. PubMed [journal] PMID: 26963595

5. Kundakovic M, Jiang Y, Kavanagh DH, Dincer A, Brown L, Pothula V, Zharovsky E,Park R, Jacobov R, Magro I, Kassim B, Wiseman J, Dang K, Sieberts SK, Roussos P, Fromer M, Harris B, Lipska BK, Peters MA, Sklar P, Akbarian S. PracticalGuidelines for High-Resolution Epigenomic Profiling of Nucleosomal Histones inPostmortem Human Brain Tissue. Biological psychiatry. 2016; PubMed [journal]PMID: 27113501

6. Halene TB, Kozlenkov A, Jiang Y, Mitchell AC, Javidfar B, Dincer A, Park R,Wiseman J, Croxson PL, Giannaris EL, Hof PR, Roussos P, Dracheva S, Hemby SE,Akbarian S. NeuN+ neuronal nuclei in non-human primate prefrontal cortex andsubcortical white matter after clozapine exposure. Schizophrenia research. 2016; 170(2-3):235-44. NIHMSID: NIHMS750072 PubMed [journal] PMID: 26776227, PMCID:PMC4740223

7. Fullard JF, Halene TB, Giambartolomei C, Haroutunian V, Akbarian S, Roussos P.Understanding the genetic liability to schizophrenia through the neuroepigenome. Schizophrenia research. 2016; NIHMSID: NIHMS755550 PubMed [journal] PMID:26827128, PMCID: PMC4963306

8. Watson CT, Roussos P, Garg P, Ho DJ, Azam N, Katsel PL, Haroutunian V, Sharp AJ. Genome-wide DNA methylation profiling in the superior temporal gyrus revealsepigenetic signatures associated with Alzheimer's disease. Genome medicine. 2016;8(1):5. PubMed [journal] PMID: 26803900, PMCID: PMC4719699

9. Schizophrenia hiPSC neurons display expression changes that are enriched fordisease risk variants and a blunted activity-dependent response Roussos P, Guennewig B, Kaczorowski D, Barry G, Brennand K.JAMA Psychiatry. 2016; :Accepted.My Bibliography [journal]

10. Cardiometabolic Risk Loci Share Downstream Cis- and Trans-Gene Regulation Across Tissues and DiseasesFranzén O, Ermel R, Cohain A, Akers N, Di Narzo A, Talukdar H, Foroughi-Asl H,Giambartolomei C, Fullard J, Sukhavasi K, Köks S, Gan L, Giannarelli C, KovacicJ, Betsholtz C, Losic B, Michoel T, Hao K, Roussos P, Skogsberg J, Ruusalepp A,Schadt E, Björkegren J.Science. 2016; :Accepted.My Bibliography [journal]

11. Gene Expression Elucidates Functional Impact of Polygenic Risk for SchizophreniaFromer M, Roussos P, Sieberts S, Johnson J, Kavanagh D, Perumal T, Ruderfer D, OhE, Topol A, Shah H, Klei L, Kramer R, Pinto D, Gumus Z, Cicek A, Dang K, BrowneA, Lu C, Xie L, Readhead B, Stahl E, Parvisi M, Hamamsy T, Fullard J, Wang Y,Mahajan M, Derry J, Dudley J, Hemby S, Logsdon B, Talbot K, Raj T, Bennett D, De Jager P, Zhu J, Zhang B, Sullivan P, Chess A, Purcell S, Shinobu L, Mangravite L,Toyoshiba H, Gur R, Hahn C, Lewis D, Haroutunian V, Peters M, Lipska B, BuxbaumJ, Schadt E, Hira K, Roeder K, Brennand K, Katsanis N, Dominici E, Devlin B,Sklar P.Nat Neurosci. 2016; :Accepted.My Bibliography [journal]

12. Akbarian S, Liu C, Knowles JA, Vaccarino FM, Farnham PJ, Crawford GE, Jaffe AE,Pinto D, Dracheva S, Geschwind DH, Mill J, Nairn AC, Abyzov A, Pochareddy S,Prabhakar S, Weissman S, Sullivan PF, State MW, Weng Z, Peters MA, White KP,Gerstein MB, Amiri A, Armoskus C, Ashley-Koch AE, Bae T, Beckel-Mitchener A,Berman BP, Coetzee GA, Coppola G, Francoeur N, Fromer M, Gao R, Grennan K,Herstein J, Kavanagh DH, Ivanov NA, Jiang Y, Kitchen RR, Kozlenkov A, Kundakovic M, Li M, Li Z, Liu S, Mangravite LM, Mattei E, Markenscoff-Papadimitriou E,Navarro FC, North N, Omberg L, Panchision D, Parikshak N, Poschmann J, Price AJ, Purcaro M, Reddy TE, Roussos P, Schreiner S, Scuderi S, Sebra R, Shibata M, ShiehAW, Skarica M, Sun W, Swarup V, Thomas A, Tsuji J, van Bakel H, Wang D, Wang Y,Wang K, Werling DM, Willsey AJ, Witt H, Won H, Wong CC, Wray GA, Wu EY, Xu X, YaoL, Senthil G, Lehner T, Sklar P, Sestan N. The PsychENCODE project. Natureneuroscience. 2015; 18(12):1707-12. NIHMSID: NIHMS741465 PubMed [journal] PMID:26605881, PMCID: PMC4675669

13. Song J, Bergen SE, Di Florio A, Karlsson R, Charney A, Ruderfer DM, Stahl EA,Chambert KD, Moran JL, Gordon-Smith K, Forty L, Green EK, Jones I, Jones L,Scolnick EM, Sklar P, Smoller JW, Lichtenstein P, Hultman C, Craddock N, LandénM, Smoller JW, Perlis RH, Lee PH, Castro VM, Hoffnagle AG, Sklar P, Stahl EA,Purcell SM, Ruderfer DM, Charney AW, Roussos P, Michele Pato CP, Medeiros H,Sobel J, Craddock N, Jones I, Forty L, Florio AD, Green E, Jones L, Gordon-Smith K, Landen M, Hultman C, Jureus A, Bergen S, McCarroll S, Moran J, Smoller JW,Chambert K, Belliveau RA. Genome-wide association study identifies SESTD1 as anovel risk gene for lithium-responsive bipolar disorder. Molecular psychiatry.2015; PubMed [journal] PMID: 26503763

14. Roussos P, Katsel P, Fam P, Tan W, Purohit DP, Haroutunian V. The triggeringreceptor expressed on myeloid cells 2 (TREM2) is associated with enhancedinflammation, neuropathological lesions and increased risk for Alzheimer'sdementia. Alzheimer's & dementia : the journal of the Alzheimer's Association.2015; 11(10):1163-70. NIHMSID: NIHMS642413 PubMed [journal] PMID: 25499537,PMCID: PMC4461564

15. Vilhjálmsson BJ, Yang J, Finucane HK, Gusev A, Lindström S, Ripke S, Genovese G, Loh PR, Bhatia G, Do R, Hayeck T, Won HH, Kathiresan S, Pato M, Pato C, Tamimi R,Stahl E, Zaitlen N, Pasaniuc B, Belbin G, Kenny EE, Schierup MH, De Jager P,Patsopoulos NA, McCarroll S, Daly M, Purcell S, Chasman D, Neale B, Goddard M,Visscher PM, Kraft P, Patterson N, Price AL. Modeling Linkage DisequilibriumIncreases Accuracy of Polygenic Risk Scores. American journal of human genetics. 2015; 97(4):576-92. PubMed [journal] PMID: 26430803, PMCID: PMC4596916

16. Won HH, Natarajan P, Dobbyn A, Jordan DM, Roussos P, Lage K, Raychaudhuri S,Stahl E, Do R. Disproportionate Contributions of Select Genomic Compartments and Cell Types to Genetic Risk for Coronary Artery Disease. PLoS genetics. 2015;11(10):e1005622. PubMed [journal] PMID: 26509271, PMCID: PMC4625039

17. Rees E, Kirov G, Walters JT, Richards AL, Howrigan D, Kavanagh DH, PocklingtonAJ, Fromer M, Ruderfer DM, Georgieva L, Carrera N, Gormley P, Palta P, WilliamsH, Dwyer S, Johnson JS, Roussos P, Barker DD, Banks E, Milanova V, Rose SA,Chambert K, Mahajan M, Scolnick EM, Moran JL, Tsuang MT, Glatt SJ, Chen WJ, HwuHG, Neale BM, Palotie A, Sklar P, Purcell SM, McCarroll SA, Holmans P, Owen MJ,O'Donovan MC. Analysis of exome sequence in 604 trios for recessive genotypes in schizophrenia. Translational psychiatry. 2015; 5:e607. PubMed [journal] PMID:26196440

18. Hatzimanolis A, Bhatnagar P, Moes A, Wang R, Roussos P, Bitsios P, Stefanis CN,Pulver AE, Arking DE, Smyrnis N, Stefanis NC, Avramopoulos D. Common geneticvariation and schizophrenia polygenic risk influence neurocognitive performancein young adulthood. American journal of medical genetics. Part B,Neuropsychiatric genetics : the official publication of the International Societyof Psychiatric Genetics. 2015; 168B(5):392-401. PubMed [journal] PMID: 25963331

19. Trampush JW, Lencz T, Knowles E, Davies G, Guha S, Pe'er I, Liewald DC, Starr JM,Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, Mukherjee S, DeRosseP, Lundervold A, Steen VM, John M, Espeseth T, Räikkönen K, Widen E, Palotie A,Eriksson JG, Giegling I, Konte B, Ikeda M, Roussos P, Giakoumaki S, Burdick KE,Payton A, Ollier W, Horan M, Scult M, Dickinson D, Straub RE, Donohoe G, MorrisD, Corvin A, Gill M, Hariri A, Weinberger DR, Pendleton N, Iwata N, Darvasi A,Bitsios P, Rujescu D, Lahti J, Le Hellard S, Keller MC, Andreassen OA, Deary IJ, Glahn DC, Malhotra AK. Independent evidence for an association between generalcognitive ability and a genetic locus for educational attainment. Americanjournal of medical genetics. Part B, Neuropsychiatric genetics : the officialpublication of the International Society of Psychiatric Genetics. 2015;168B(5):363-73. NIHMSID: NIHMS35514 PubMed [journal] PMID: 25951819, PMCID:PMC4500051

20. O'Donovan SM, Hasselfeld K, Bauer D, Simmons M, Roussos P, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE. Glutamate transporter splice variantexpression in an enriched pyramidal cell population in schizophrenia.Translational psychiatry. 2015; 5:e579. PubMed [journal] PMID: 26057049, PMCID:PMC4490284

21. Pasparakis E, Koiliari E, Zouraraki C, Tsapakis EM, Roussos P, Giakoumaki SG,Bitsios P. The effects of the CACNA1C rs1006737 A/G on affective startlemodulation in healthy males. European psychiatry : the journal of the Associationof European Psychiatrists. 2015; 30(4):492-8. PubMed [journal] PMID: 25841664

22. Xu K, Schadt EE, Pollard KS, Roussos P, Dudley JT. Genomic and network patternsof schizophrenia genetic variation in human evolutionary accelerated regions.Molecular biology and evolution. 2015; 32(5):1148-60. PubMed [journal] PMID:25681384, PMCID: PMC4408416

23. Hertzberg L, Katsel P, Roussos P, Haroutunian V, Domany E. Integration of geneexpression and GWAS results supports involvement of calcium signaling inSchizophrenia. Schizophrenia research. 2015; 164(1-3):92-9. PubMed [journal]PMID: 25702973

24. Castro VM, Minnier J, Murphy SN, Kohane I, Churchill SE, Gainer V, Cai T,Hoffnagle AG, Dai Y, Block S, Weill SR, Nadal-Vicens M, Pollastri AR, Rosenquist JN, Goryachev S, Ongur D, Sklar P, Perlis RH, Smoller JW. Validation ofelectronic health record phenotyping of bipolar disorder cases and controls. The American journal of psychiatry. 2015; 172(4):363-72. NIHMSID: NIHMS663967 PubMed [journal] PMID: 25827034, PMCID: PMC4441333

25. Bulik-Sullivan BK, Loh PR, Finucane HK, Ripke S, Yang J, Patterson N, Daly MJ,Price AL, Neale BM. LD Score regression distinguishes confounding frompolygenicity in genome-wide association studies. Nature genetics. 2015;47(3):291-5. NIHMSID: NIHMS683841 PubMed [journal] PMID: 25642630, PMCID:PMC4495769

26. Dong X, Tsuji J, Labadorf A, Roussos P, Chen JF, Myers RH, Akbarian S, Weng Z.The Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington'sDisease. PloS one. 2015; 10(12):e0144398. PubMed [journal] PMID: 26636336, PMCID:PMC4670094

27. Bharadwaj R, Peter CJ, Jiang Y, Roussos P, Vogel-Ciernia A, Shen EY, Mitchell AC,Mao W, Whittle C, Dincer A, Jakovcevski M, Pothula V, Rasmussen TP, GiakoumakiSG, Bitsios P, Sherif A, Gardner PD, Ernst P, Ghose S, Sklar P, Haroutunian V,Tamminga C, Myers RH, Futai K, Wood MA, Akbarian S. Conserved higher-orderchromatin regulates NMDA receptor gene expression and cognition. Neuron. 2014;84(5):997-1008. NIHMSID: NIHMS639571 PubMed [journal] PMID: 25467983, PMCID:PMC4258154

28. Roussos P, Mitchell AC, Voloudakis G, Fullard JF, Pothula VM, Tsang J, Stahl EA, Georgakopoulos A, Ruderfer DM, Charney A, Okada Y, Siminovitch KA, Worthington J,Padyukov L, Klareskog L, Gregersen PK, Plenge RM, Raychaudhuri S, Fromer M,Purcell SM, Brennand KJ, Robakis NK, Schadt EE, Akbarian S, Sklar P. A role fornoncoding variation in schizophrenia. Cell reports. 2014; 9(4):1417-29. NIHMSID: NIHMS635106 PubMed [journal] PMID: 25453756, PMCID: PMC4255904

29. Gusev A, Lee SH, Trynka G, Finucane H, Vilhjálmsson BJ, Xu H, Zang C, Ripke S,Bulik-Sullivan B, Stahl E, Kähler AK, Hultman CM, Purcell SM, McCarroll SA, Daly M, Pasaniuc B, Sullivan PF, Neale BM, Wray NR, Raychaudhuri S, Price AL.Partitioning heritability of regulatory and cell-type-specific variants across 11common diseases. American journal of human genetics. 2014; 95(5):535-52. PubMed[journal] PMID: 25439723, PMCID: PMC4225595

30. Haroutunian V, Katsel P, Roussos P, Davis KL, Altshuler LL, Bartzokis G.Myelination, oligodendrocytes, and serious mental illness. Glia. 2014;62(11):1856-77. PubMed [journal] PMID: 25056210

31. Di Narzo AF, Kozlenkov A, Roussos P, Hao K, Hurd Y, Lewis DA, Sibille E, SieverLJ, Koonin E, Dracheva S. A unique gene expression signature associated withserotonin 2C receptor RNA editing in the prefrontal cortex and altered insuicide. Human molecular genetics. 2014; 23(18):4801-13. PubMed [journal] PMID:24781207, PMCID: PMC4140462

32. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421-7. NIHMSID: EMS59304 PubMed [journal] PMID: 25056061, PMCID:PMC4112379

33. Koiliari E, Roussos P, Pasparakis E, Lencz T, Malhotra A, Siever LJ, GiakoumakiSG, Bitsios P. The CSMD1 genome-wide associated schizophrenia risk variantrs10503253 affects general cognitive ability and executive function in healthymales. Schizophrenia research. 2014; 154(1-3):42-7. PubMed [journal] PMID:24630139

34. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P, O'DushlaineC, Chambert K, Bergen SE, Kähler A, Duncan L, Stahl E, Genovese G, Fernández E,Collins MO, Komiyama NH, Choudhary JS, Magnusson PK, Banks E, Shakir K, GarimellaK, Fennell T, DePristo M, Grant SG, Haggarty SJ, Gabriel S, Scolnick EM, LanderES, Hultman CM, Sullivan PF, McCarroll SA, Sklar P. A polygenic burden of raredisruptive mutations in schizophrenia. Nature. 2014; 506(7487):185-90. NIHMSID:NIHMS588038 PubMed [journal] PMID: 24463508, PMCID: PMC4136494

35. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, GeorgievaL, Rees E, Palta P, Ruderfer DM, Carrera N, Humphreys I, Johnson JS, Roussos P,Barker DD, Banks E, Milanova V, Grant SG, Hannon E, Rose SA, Chambert K, Mahajan M, Scolnick EM, Moran JL, Kirov G, Palotie A, McCarroll SA, Holmans P, Sklar P,Owen MJ, Purcell SM, O'Donovan MC. De novo mutations in schizophrenia implicatesynaptic networks. Nature. 2014; 506(7487):179-84. NIHMSID: EMS60947 PubMed[journal] PMID: 24463507, PMCID: PMC4237002

36. Lencz T, Knowles E, Davies G, Guha S, Liewald DC, Starr JM, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, Mukherjee S, DeRosse P, Lundervold A, SteenVM, John M, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I,Konte B, Ikeda M, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Horan M, Donohoe G, Morris D, Corvin A, Gill M, Pendleton N, Iwata N, Darvasi A,Bitsios P, Rujescu D, Lahti J, Hellard SL, Keller MC, Andreassen OA, Deary IJ,Glahn DC, Malhotra AK. Molecular genetic evidence for overlap between generalcognitive ability and risk for schizophrenia: a report from the CognitiveGenomics consorTium (COGENT). Molecular psychiatry. 2014; 19(2):168-74. NIHMSID: NIHMS560312 PubMed [journal] PMID: 24342994, PMCID: PMC3968799

37. Roussos P, Haroutunian V. Schizophrenia: susceptibility genes andoligodendroglial and myelin related abnormalities. Frontiers in cellularneuroscience. 2014; 8:5. PubMed [journal] PMID: 24478629, PMCID: PMC3896818

38. Kozlenkov A, Roussos P, Timashpolsky A, Barbu M, Rudchenko S, Bibikova M, KlotzleB, Byne W, Lyddon R, Di Narzo AF, Hurd YL, Koonin EV, Dracheva S. Differences in DNA methylation between human neuronal and glial cells are concentrated inenhancers and non-CpG sites. Nucleic acids research. 2014; 42(1):109-27. PubMed[journal] PMID: 24057217, PMCID: PMC3874157

39. Mitchell A, Roussos P, Peter C, Tsankova N, Akbarian S. The future ofneuroepigenetics in the human brain. Progress in molecular biology andtranslational science. 2014; 128:199-228. NIHMSID: NIHMS781658 PubMed [journal]PMID: 25410546, PMCID: PMC4863594

Katherine Burdick  (MIRECC-Associated) 16 of 89 (Total)

1: Oedegaard KJ, Alda M, Anand A, Andreassen OA, Balaraman Y, Berrettini WH, Bhattacharjee A, Brennand KJ, Burdick KE, Calabrese JR, Calkin CV, Claasen A, Coryell WH, Craig D, DeModena A, Frye M, Gage FH, Gao K, Garnham J, Gershon E, Jakobsen P, Leckband SG, McCarthy MJ, McInnis MG, Maihofer AX, Mertens J, Morken G, Nievergelt CM, Nurnberger J, Pham S, Schoeyen H, Shekhtman T, Shilling PD, Szelinger S, Tarwater B, Yao J, Zandi PP, Kelsoe JR. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a  prospective sample. BMC Psychiatry. 2016 May 5;16:129. doi: 10.1186/s12888-016-0732-x. PubMed PMID: 27150464; PubMed Central PMCID: PMC4857276.

2: Nitzburg GC, Russo M, Cuesta-Diaz A, Ospina L, Shanahan M, Perez-Rodriguez M, McGrath M, Burdick KE. Coping strategies and real-world functioning in bipolar disorder. J Affect Disord. 2016 Jul 1;198:185-8. doi: 10.1016/j.jad.2016.03.028. Epub 2016 Mar 15. PubMed PMID: 27017375; PubMed Central PMCID: PMC4859149.

3: Trampush JW, Lencz T, DeRosse P, John M, Gallego JA, Petrides G, Hassoun Y, Zhang JP, Addington J, Kellner CH, Tohen M, Burdick KE, Goldberg TE, Kane JM, Robinson DG, Malhotra AK. Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders. Schizophr Bull. 2015 Nov;41(6):1237-47. doi: 10.1093/schbul/sbv120. Epub 2015 Sep 25. PubMed PMID: 26409223; PubMed Central PMCID: PMC4601719.

4: Howrigan DP, Simonson MA, Davies G, Harris SE, Tenesa A, Starr JM, Liewald DC, Deary IJ, McRae A, Wright MJ, Montgomery GW, Hansell N, Martin NG, Payton A, Horan M, Ollier WE, Abdellaoui A, Boomsma DI, DeRosse P, Knowles EE, Glahn DC,  Djurovic S, Melle I, Andreassen OA, Christoforou A, Steen VM, Hellard SL, Sundet K, Reinvang I, Espeseth T, Lundervold AJ, Giegling I, Konte B, Hartmann AM, Rujescu D, Roussos P, Giakoumaki S, Burdick KE, Bitsios P, Donohoe G, Corley RP,  Visscher PM, Pendleton N, Malhotra AK, Neale BM, Lencz T, Keller MC. Genome-wide autozygosity is associated with lower general cognitive ability. Mol Psychiatry.  2016 Jun;21(6):837-43. doi: 10.1038/mp.2015.120. Epub 2015 Sep 22. PubMed PMID:  26390830; PubMed Central PMCID: PMC4803638.

5: Russo M, Mahon K, Shanahan M, Ramjas E, Solon C, Purcell SM, Burdick KE. The relationship between sleep quality and neurocognition in bipolar disorder. Affect Disord. 2015 Nov 15;187:156-62. doi: 10.1016/j.jad.2015.08.009. Epub 2015  Aug 28. PubMed PMID: 26339925; PubMed Central PMCID: PMC4598049.

6: Trampush JW, Lencz T, Knowles E, Davies G, Guha S, Pe'er I, Liewald DC, Starr JM, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, Mukherjee S, DeRosse P, Lundervold A, Steen VM, John M, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Ikeda M, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Horan M, Scult M, Dickinson D, Straub RE, DonohoeG, Morris D, Corvin A, Gill M, Hariri A, Weinberger DR, Pendleton N, Iwata N, Darvasi A, Bitsios P, Rujescu D, Lahti J, Le Hellard S, Keller MC, Andreassen OA, Deary IJ, Glahn DC, Malhotra AK. Independent evidence for an association between  general cognitive ability and a genetic locus for educational attainment. Am J Med Genet B Neuropsychiatr Genet. 2015 Jul;168B(5):363-73. doi: 10.1002/ajmg.b.32319. Epub 2015 May 7. PubMed PMID: 25951819; PubMed Central PMCID: PMC4500051.

7: Burdick KE, Ketter TA, Goldberg JF, Calabrese JR. Assessing cognitive functionin bipolar disorder: challenges and recommendations for clinical trial design. J Clin Psychiatry. 2015 Mar;76(3):e342-50. doi: 10.4088/JCP.14cs09399. PubMed PMID:25830456; PubMed Central PMCID: PMC4472380.

8: Toteja N, Guvenek-Cokol P, Ikuta T, Kafantaris V, Peters BD, Burdick KE, John M, Malhotra AK, Szeszko PR. Age-associated alterations in corpus callosum whitematter integrity in bipolar disorder assessed using probabilistic tractography.Bipolar Disord. 2015 Jun;17(4):381-91. doi: 10.1111/bdi.12278. Epub 2014 Dec 22. PubMed PMID: 25532972; PubMed Central PMCID: PMC4458202.

9: Russo M, Mahon K, Burdick KE. Measuring cognitive function in MDD: emergingassessment tools. Depress Anxiety. 2015 Apr;32(4):262-9. doi: 10.1002/da.22297.Epub 2014 Nov 24. Review. PubMed PMID: 25421437; PubMed Central PMCID:PMC4407945.

10: Murrough JW, Burdick KE, Levitch CF, Perez AM, Brallier JW, Chang LC, FoulkesA, Charney DS, Mathew SJ, Iosifescu DV. Neurocognitive effects of ketamine andassociation with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial. Neuropsychopharmacology. 2015 Mar13;40(5):1084-90. doi: 10.1038/npp.2014.298. PubMed PMID: 25374095; PubMedCentral PMCID: PMC4367458.

11: Mercedes Perez-Rodriguez M, Mahon K, Russo M, Ungar AK, Burdick KE. Oxytocin and social cognition in affective and psychotic disorders. EurNeuropsychopharmacol. 2015 Feb;25(2):265-82. doi:10.1016/j.euroneuro.2014.07.012. Epub 2014 Aug 1. Review. PubMed PMID: 25153535; PubMed Central PMCID: PMC4443696.

12: Russo M, Mahon K, Shanahan M, Ramjas E, Solon C, Braga RJ, Burdick KE.Affective temperaments and neurocognitive functioning in bipolar disorder. JAffect Disord. 2014 Dec;169:51-6. doi: 10.1016/j.jad.2014.07.038. Epub 2014 Aug5. PubMed PMID: 25151191; PubMed Central PMCID: PMC4172290.

13: Burdick KE, Russo M, Frangou S, Mahon K, Braga RJ, Shanahan M, Malhotra AK.Empirical evidence for discrete neurocognitive subgroups in bipolar disorder:clinical implications. Psychol Med. 2014 Oct;44(14):3083-96. doi:10.1017/S0033291714000439. Epub 2014 Mar 11. PubMed PMID: 25065409; PubMedCentral PMCID: PMC4797987.

14: Keefe RS, Fox KH, Davis VG, Kennel C, Walker TM, Burdick KE, Harvey PD. TheBrief Assessment of Cognition In Affective Disorders (BAC-A):performance ofpatients with bipolar depression and healthy controls. J Affect Disord. 2014Sep;166:86-92. doi: 10.1016/j.jad.2014.05.002. Epub 2014 May 11. PubMed PMID:25012414.

15: Lencz T, Knowles E, Davies G, Guha S, Liewald DC, Starr JM, Djurovic S, MelleI, Sundet K, Christoforou A, Reinvang I, Mukherjee S, DeRosse P, Lundervold A,Steen VM, John M, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG,Giegling I, Konte B, Ikeda M, Roussos P, Giakoumaki S, Burdick KE, Payton A,Ollier W, Horan M, Donohoe G, Morris D, Corvin A, Gill M, Pendleton N, Iwata N,Darvasi A, Bitsios P, Rujescu D, Lahti J, Hellard SL, Keller MC, Andreassen OA,Deary IJ, Glahn DC, Malhotra AK. Molecular genetic evidence for overlap betweengeneral cognitive ability and risk for schizophrenia: a report from the CognitiveGenomics consorTium (COGENT). Mol Psychiatry. 2014 Feb;19(2):168-74. doi:10.1038/mp.2013.166. Epub 2013 Dec 17. PubMed PMID: 24342994; PubMed CentralPMCID: PMC3968799.

16: Nitzburg GC, Derosse P, Burdick KE, Peters BD, Gopin CB, Malhotra AK. MATRICScognitive consensus battery (MCCB) performance in children, adolescents, andyoung adults. Schizophr Res. 2014 Jan;152(1):223-8. doi:10.1016/j.schres.2013.11.023. Epub 2013 Dec 8. PubMed PMID: 24321710; PubMedCentral PMCID: PMC3918455.

Victoria Haghighi (MIRECC-Associated) 8 of 42 (Total)

 

http://www.ncbi.nlm.nih.gov/sites/myncbi/1R1O_ls6XviAz/bibliography/46030203/public/?sort=date&direction=descending

 

1. Galfalvy H, Haghighi F, Hodgkinson C, Goldman D, Oquendo MA, Burke A, Huang YY,Giegling I, Rujescu D, Bureau A, Turecki G, Mann JJ. A genome-wide associationstudy of suicidal behavior. American journal of medical genetics. Part B,Neuropsychiatric genetics : the official publication of the International Societyof Psychiatric Genetics. 2015; 168(7):557-63. PubMed [journal] PMID: 26079190

2. Haghighi F, Ge Y, Chen S, Xin Y, Umali MU, De Gasperi R, Gama Sosa MA, Ahlers ST,Elder GA. Neuronal DNA Methylation Profiling of Blast-Related Traumatic BrainInjury. Journal of neurotrauma. 2015; 32(16):1200-9. PubMed [journal] PMID:25594545, PMCID: PMC4532898

3. Milekic MH, Xin Y, O'Donnell A, Kumar KK, Bradley-Moore M, Malaspina D, Moore H, Brunner D, Ge Y, Edwards J, Paul S, Haghighi FG, Gingrich JA. Age-related spermDNA methylation changes are transmitted to offspring and associated with abnormalbehavior and dysregulated gene expression. Molecular psychiatry. 2015;20(8):995-1001. PubMed [journal] PMID: 25092244

4. Elder GA, Gama Sosa MA, De Gasperi R, Stone JR, Dickstein DL, Haghighi F, Hof PR,Ahlers ST. Vascular and inflammatory factors in the pathophysiology ofblast-induced brain injury. Frontiers in neurology. 2015; 6:48. PubMed [journal] PMID: 25852632, PMCID: PMC4360816

5. Gross JA, Bureau A, Croteau J, Galfalvy H, Oquendo MA, Haghighi F, Mérette C,Giegling I, Hodgkinson C, Goldman D, Rujescu D, Mann JJ, Turecki G. A genome-widecopy number variant study of suicidal behavior. PloS one. 2015; 10(5):e0128369.PubMed [journal] PMID: 26010658, PMCID: PMC4444178

6. Haghighi F, Galfalvy H, Chen S, Huang YY, Cooper TB, Burke AK, Oquendo MA, MannJJ, Sublette ME. DNA methylation perturbations in genes involved inpolyunsaturated Fatty Acid biosynthesis associated with depression and suiciderisk. Frontiers in neurology. 2015; 6:92. PubMed [journal] PMID: 25972837, PMCID:PMC4412056

7. Haghighi F, Xin Y, Chanrion B, O'Donnell AH, Ge Y, Dwork AJ, Arango V, Mann JJ.Increased DNA methylation in the suicide brain. Dialogues in clinicalneuroscience. 2014; 16(3):430-8. PubMed [journal] PMID: 25364291, PMCID:PMC4214183

8. Hodges LM, Fyer AJ, Weissman MM, Logue MW, Haghighi F, Evgrafov O, Rotondo A,Knowles JA, Hamilton SP. Evidence for linkage and association of GABRB3 andGABRA5 to panic disorder. Neuropsychopharmacology : official publication of theAmerican College of Neuropsychopharmacology. 2014; 39(10):2423-31. PubMed[journal] PMID: 24755890, PMCID: PMC4138754

Philip Szeszko (MIRECC-Associated) 25 of 92 (Total)

http://www.ncbi.nlm.nih.gov/sites/myncbi/1L3xkz7Fb1jQC/bibliography/40829713/public/?sort=date&direction=ascending.

1: DeRosse P, Ikuta T, Karlsgodt KH, Peters BD, Gopin CB, Szeszko PR, MalhotraAK. White Matter Abnormalities Associated With Subsyndromal Psychotic-LikeSymptoms Predict Later Social Competence in Children and Adolescents. SchizophrBull. 2016 May 17. pii: sbw062. [Epub ahead of print] PubMed PMID: 27190281.

2: Schwehm A, Robinson DG, Gallego JA, Karlsgodt KH, Ikuta T, Peters BD, MalhotraAK, Szeszko PR. Age and Sex Effects on White Matter Tracts in Psychosis fromAdolescence through Middle Adulthood. Neuropsychopharmacology. 2016Sep;41(10):2473-80. doi: 10.1038/npp.2016.47. Epub 2016 Apr 12. PubMed PMID:27067129.

3: Voineskos AN, Felsky D, Wheeler AL, Rotenberg DJ, Levesque M, Patel S, SzeszkoPR, Kennedy JL, Lencz T, Malhotra AK. Limited Evidence for Association ofGenome-Wide Schizophrenia Risk Variants on Cortical Neuroimaging Phenotypes.Schizophr Bull. 2016 Jul;42(4):1027-36. doi: 10.1093/schbul/sbv180. Epub 2015 Dec27. PubMed PMID: 26712857; PubMed Central PMCID: PMC4903045.

4: Karlsgodt KH, John M, Ikuta T, Rigoard P, Peters BD, Derosse P, Malhotra AK, Szeszko PR. The accumbofrontal tract: Diffusion tensor imaging characterizationand developmental change from childhood to adulthood. Hum Brain Mapp. 2015Dec;36(12):4954-63. doi: 10.1002/hbm.22989. Epub 2015 Sep 14. PubMed PMID:26366528; PubMed Central PMCID: PMC4715564.

5: Sarpal DK, Argyelan M, Robinson DG, Szeszko PR, Karlsgodt KH, John M, WeissmanN, Gallego JA, Kane JM, Lencz T, Malhotra AK. Baseline Striatal FunctionalConnectivity as a Predictor of Response to Antipsychotic Drug Treatment. Am JPsychiatry. 2016 Jan;173(1):69-77. doi: 10.1176/appi.ajp.2015.14121571. Epub 2015Aug 28. PubMed PMID: 26315980; PubMed Central PMCID: PMC4845897.

6: Ikuta T, DeRosse P, Argyelan M, Karlsgodt KH, Kingsley PB, Szeszko PR,Malhotra AK. Subcortical modulation in auditory processing and auditoryhallucinations. Behav Brain Res. 2015 Dec 15;295:78-81. doi:10.1016/j.bbr.2015.08.009. Epub 2015 Aug 11. PubMed PMID: 26275927; PubMedCentral PMCID: PMC4641005.

7: Prendergast DM, Ardekani B, Ikuta T, John M, Peters B, DeRosse P, WellingtonR, Malhotra AK, Szeszko PR. Age and sex effects on corpus callosum morphologyacross the lifespan. Hum Brain Mapp. 2015 Jul;36(7):2691-702. doi:10.1002/hbm.22800. Epub 2015 Apr 2. PubMed PMID: 25833103; PubMed Central PMCID: PMC4478157.

8: Wheeler AL, Wessa M, Szeszko PR, Foussias G, Chakravarty MM, Lerch JP, DeRosseP, Remington G, Mulsant BH, Linke J, Malhotra AK, Voineskos AN. Furtherneuroimaging evidence for the deficit subtype of schizophrenia: a corticalconnectomics analysis. JAMA Psychiatry. 2015 May;72(5):446-55. doi:10.1001/jamapsychiatry.2014.3020. PubMed PMID: 25786193.

9: Shafritz KM, Bregman JD, Ikuta T, Szeszko PR. Neural systems mediatingdecision-making and response inhibition for social and nonsocial stimuli inautism. Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jul 3;60:112-20. doi:10.1016/j.pnpbp.2015.03.001. Epub 2015 Mar 10. PubMed PMID: 25765593; PubMedCentral PMCID: PMC4426235.

10: Karlsgodt KH, Bato AA, Blair MA, DeRosse P, Szeszko PR, Malhotra AK. Whitematter microstructure in the executive network associated with aggression inhealthy adolescents and young adults. Soc Cogn Affect Neurosci. 2015Sep;10(9):1251-6. doi: 10.1093/scan/nsv015. Epub 2015 Feb 17. PubMed PMID:25691778; PubMed Central PMCID: PMC4560949.

11: Argyelan M, Gallego JA, Robinson DG, Ikuta T, Sarpal D, John M, Kingsley PB, Kane J, Malhotra AK, Szeszko PR. Abnormal resting state FMRI activity predictsprocessing speed deficits in first-episode psychosis. Neuropsychopharmacology.2015 Jun;40(7):1631-9. doi: 10.1038/npp.2015.7. Epub 2015 Jan 8. PubMed PMID:25567423; PubMed Central PMCID: PMC4915267.

12: Toteja N, Guvenek-Cokol P, Ikuta T, Kafantaris V, Peters BD, Burdick KE, JohnM, Malhotra AK, Szeszko PR. Age-associated alterations in corpus callosum whitematter integrity in bipolar disorder assessed using probabilistic tractography.Bipolar Disord. 2015 Jun;17(4):381-91. doi: 10.1111/bdi.12278. Epub 2014 Dec 22. PubMed PMID: 25532972; PubMed Central PMCID: PMC4458202.

13: DeRosse P, Nitzburg GC, Ikuta T, Peters BD, Malhotra AK, Szeszko PR. Evidencefrom structural and diffusion tensor imaging for frontotemporal deficits inpsychometric schizotypy. Schizophr Bull. 2015 Jan;41(1):104-14. doi:10.1093/schbul/sbu150. Epub 2014 Nov 11. PubMed PMID: 25392520; PubMed CentralPMCID: PMC4266309.

14: Sarpal DK, Robinson DG, Lencz T, Argyelan M, Ikuta T, Karlsgodt K, GallegoJA, Kane JM, Szeszko PR, Malhotra AK. Antipsychotic treatment and functionalconnectivity of the striatum in first-episode schizophrenia. JAMA Psychiatry.2015 Jan;72(1):5-13. doi: 10.1001/jamapsychiatry.2014.1734. PubMed PMID:25372846; PubMed Central PMCID: PMC4286512.

15: DeRosse P, Ikuta T, Peters BD, Karlsgodt KH, Szeszko PR, Malhotra AK. Adding insult to injury: childhood and adolescent risk factors for psychosis predictlower fractional anisotropy in the superior longitudinal fasciculus in healthyadults. Psychiatry Res. 2014 Dec 30;224(3):296-302. doi:10.1016/j.pscychresns.2014.09.001. Epub 2014 Sep 16. PubMed PMID: 25277095;PubMed Central PMCID: PMC4253644.

16: Szeszko PR. Aggression in schizophrenia and its relationship to neuralcircuitry of urgency. Am J Psychiatry. 2014 Sep;171(9):897-900. doi:10.1176/appi.ajp.2014.14050629. PubMed PMID: 25178743; PubMed Central PMCID:PMC4388323.

17: Rhindress K, Ikuta T, Wellington R, Malhotra AK, Szeszko PR. Delineation ofhippocampal subregions using T1-weighted magnetic resonance images at 3 Tesla.Brain Struct Funct. 2015 Nov;220(6):3259-72. doi: 10.1007/s00429-014-0854-1. Epub2014 Aug 1. PubMed PMID: 25081550; PubMed Central PMCID: PMC4362783.

18: Gruner P, Vo A, Argyelan M, Ikuta T, Degnan AJ, John M, Peters BD, MalhotraAK, Uluğ AM, Szeszko PR. Independent component analysis of resting state activityin pediatric obsessive-compulsive disorder. Hum Brain Mapp. 2014Oct;35(10):5306-15. doi: 10.1002/hbm.22551. Epub 2014 May 28. PubMed PMID:24867148; PubMed Central PMCID: PMC4169329.

19: Peters BD, Voineskos AN, Szeszko PR, Lett TA, DeRosse P, Guha S, KarlsgodtKH, Ikuta T, Felsky D, John M, Rotenberg DJ, Kennedy JL, Lencz T, Malhotra AK.Brain white matter development is associated with a human-specific haplotypeincreasing the synthesis of long chain fatty acids. J Neurosci. 2014 Apr30;34(18):6367-76. doi: 10.1523/JNEUROSCI.2818-13.2014. PubMed PMID: 24790207;PubMed Central PMCID: PMC4004819.

20: Ikuta T, Peters BD, Guha S, John M, Karlsgodt KH, Lencz T, Szeszko PR,Malhotra AK. A schizophrenia risk gene, ZNF804A, is associated with brain whitematter microstructure. Schizophr Res. 2014 May;155(1-3):15-20. doi:10.1016/j.schres.2014.03.001. Epub 2014 Mar 27. PubMed PMID: 24685285; PubMedCentral PMCID: PMC4060886.

21: Szeszko PR, Robinson DG, Ikuta T, Peters BD, Gallego JA, Kane J, Malhotra AK.White matter changes associated with antipsychotic treatment in first-episodepsychosis. Neuropsychopharmacology. 2014 May;39(6):1324-31. doi:10.1038/npp.2013.288. Epub 2013 Oct 16. PubMed PMID: 24549105; PubMed CentralPMCID: PMC3988536.

22: Ikuta T, Shafritz KM, Bregman J, Peters BD, Gruner P, Malhotra AK, Szeszko PR. Abnormal cingulum bundle development in autism: a probabilistic tractography study. Psychiatry Res. 2014 Jan 30;221(1):63-8. doi:10.1016/j.pscychresns.2013.08.002. Epub 2013 Nov 11. PubMed PMID: 24231056;PubMed Central PMCID: PMC3918471.

23: Ikuta T, Robinson DG, Gallego JA, Peters BD, Gruner P, Kane J, John M, SevyS, Malhotra AK, Szeszko PR. Subcortical modulation of attentional control bysecond-generation antipsychotics in first-episode psychosis. Psychiatry Res. 2014Feb 28;221(2):127-34. doi: 10.1016/j.pscychresns.2013.09.010. Epub 2013 Oct 10.PubMed PMID: 24120303; PubMed Central PMCID: PMC3946302.

24: Argyelan M, Ikuta T, DeRosse P, Braga RJ, Burdick KE, John M, Kingsley PB,Malhotra AK, Szeszko PR. Resting-state fMRI connectivity impairment inschizophrenia and bipolar disorder. Schizophr Bull. 2014 Jan;40(1):100-10. doi:10.1093/schbul/sbt092. Epub 2013 Jul 12. PubMed PMID: 23851068; PubMed CentralPMCID: PMC3885301.

25: Peters BD, Ikuta T, DeRosse P, John M, Burdick KE, Gruner P, Prendergast DM, Szeszko PR, Malhotra AK. Age-related differences in white matter tractmicrostructure are associated with cognitive performance from childhood toadulthood. Biol Psychiatry. 2014 Feb 1;75(3):248-56. doi:10.1016/j.biopsych.2013.05.020. Epub 2013 Jul 2. PubMed PMID: 23830668; PubMedCentral PMCID: PMC4412928.

Contact

VISN 2 South MIRECC Main Office
JJP VAMC Room 6A-44
718-584-9000 Ext. 5227